Log in Register

Login to your account

Username
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name
Username
Password *
Verify password *
Email *
Verify email *
Captcha *

Articles

JASN Editorials 2005

ISSUE
EDITORIAL
December 2005 Vol.16;12
(1) Autotopes and Allotopes
(2)Novel Mechanism of P-Fimbriated Escherichia coli Virulence in Polynephritis
(3)Race and Kidney Disease Outcomes: Genes or Environment?
November 2005 Vol.16;11
(1) More Targeted Treatment for Lupus Nephritis: Is the Future (Nearly) Here?
(2)Towards a Definition and Classification of Acute Kidney Injury
October 2005 Vol.16;10
(1) Molecular Physiology of Renal Acquaporins and Sodium Transporters: Exciting Approaches to Understand Regulation of Renal Water Handling
(2)Role of Podocytes in Focal Sclerosis: Defining the Point of No Return
(3)Intravenous Iron: How Much, Is Too Much?
September 2005 Vol.16;9
(1) JASN Public Access Policy
(2)Thrombotic Microangiopathy;The Nex Big Hurdle for Xenotransplantation
(3)Mechanisms and Fetal Origins of Kidney Disease
August 2005 Vol.16;8
(1) Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy: It's All the RAGE
(2)Asymmetric Dimethylarginine and Kidney Disease--Marker or Mediator?
July 2005 Vol.16;7
(1) Rapamycin: A New String to the Antiproteinuric Bow?
(2)Assoction of Metabolic Syndrome in Non Diabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings
(3)Albuminuria, Just A Marker for Cardiovascular Disease, Or Is It More?
June 2005 Vol.16;6
(1) Regulating Renal Drug Elimination?
(2)Linking Metabolism and Immunology: Diabetic Nephropathy in an Inflammatory Disease
(3)Beyond Framingham: Cardiovascular Risk Profiling in ESRD
May 2005 Vol.16;5
(1) Medicare ESRD Porspective Payment System: Weighing the Evidence
(2)An You Thought the Age of Anatomic Discovery Was Over
(3)Tipping the Balance in Glomerulonephritis
April 2005 Vol.16;4
(1) Uniform Clinical Trial Registration Policy for Journals of Kidney Diseases, Dialysis, and Transplantation
(2)V2 Receptor Antagonists in Cystic Kidney Diseases:An Exciting Step Towards a Practical Treatment
(3)Is Regression of Chronic Nephropathies a Therapeutic Target?
(4)Cardiovascular Risk Evaluation before Kidney Transplantation
March 2005 Vol.16;3
(1) Type 2 Diabetic Nephropathy:Never too Early to Treat?
February 2005 Vol.16;2
(1) Uroguanylin: Physiological Role as a Natriuretic Hormone
(2)Calcification or Classification?
January 2005 Vol.16;1
(1) The New JASN
(2)Wound Healing in the Kidney: Complex Interactions in the Renal Interstitial Fibrogenesis
(3)Acute Renal Failure and Cardiac Suregry:Marching in Place or Moving Ahead?